Research Topics


The U4 Blog

Learning & events

About Us

Covid-19 vaccines and corruption risks 

Resource from others

Covid-19 vaccines and corruption risks 

This publication is from . Some of the content may be outdated. Search related topics to find more recent resources.

The scale and complexity of the allocation, distribution and prioritisation of the Covid-19 vaccines are unprecedented. The 2020 UNODC publication Covid-19 vaccines and corruption risks: preventing corruption in the manufacture, allocation and distribution of vaccines identifies potential corruption risks related to the deployment of Covid-19 vaccines and how these risks may be mitigated.

The paper looks at corruption risks in the development, deployment, procurement of vaccines. It also describes corruption risks in emergency funding, the proliferation of substandard and falsified vaccines, nepotism and favouritism in vaccine access, and corruption in vaccine policy decisions. To mitigate these risks, UNODC provides both immediate and long-term policy recommendations. 


    All views in this text are the author(s)’, and may differ from the U4 partner agencies’ policies.

    This work is licenced under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0)